Novel therapeutic option for refractory heart failure in elderly patients with chronic kidney disease by incremental peritoneal dialysis

Journal of Cardiology

Volumn 55, Issue 1, 2010, Pages 49-54

  Nakayama, Masaru ^a   Nakano, Hirofumi ^b   Nakayama, Masaaki ^c  

^a Kashima Hospital   (Japan)

^b Kashima Hospital   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aging; Chronic kidney disease (CKD); Heart failure; Peritoneal dialysis; Renal function

Indexed keywords

ALDOSTERONE; BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN;

AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ELDERLY CARE; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE; HEMOFILTRATION; HUMAN; KIDNEY FUNCTION; MALE; PERITONEAL DIALYSIS;

AGED; AGED, 80 AND OVER; ALDOSTERONE; DIURETICS; FEMALE; FUROSEMIDE; HEART FAILURE; HEMOFILTRATION; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; NATRIURETIC PEPTIDE, BRAIN; PERITONEAL DIALYSIS;

EID: 72449212204     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.08.003     Document Type: Article

References (25)

1. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 (1991) 293-302
2. Kjekshus J., Swedberg K., and Snapinn S. Effects of enalapril on long-term mortality in severe congestive heart failure. CONSENSUS Trial Group. Am J Cardiol 69 (1992) 103-107
3. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A., Palensky J., and Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341 (1999) 709-717
4. Bristow M.R., Gilbert E.M., Abraham W.T., Adams K.F., Fowler M.B., Hershberger R.E., Kubo S.H., Narahara K.A., Ingersoll H., Krueger S., Young S., and Shusterman N. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 94 (1996) 2807-2816
5. Gottdiener J.S., McClelland R.L., Marshall R., Shemanski L., Furberg C.D., Kitzman D.W., Cushman M., Polak J., Gardin J.M., Gersh B.J., Aurigemma G.P., and Manolio T.A. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 137 (2002) 631-639
6. Tehrani F., Phan A., Chien C.V., Morrissey R.P., Rafique A.M., and Schwarz E.R. Value of medical therapy in patients >80 years of age with heart failure and preserved ejection fraction. Am J Cardiol 103 (2009) 829-833
7. Ellison D.H. Diuretic therapy and resistance in congestive heart failure. Cardiology 96 (2001) 132-143
8. Gotloib L., Fudin R., Yakubovich M., and Vienken J. Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation. Nephrol Dial Transplant 20 (2005) 32-36
9. Costanzo M.R., Guglin M.E., Saltzberg M.T., Jessup M.L., Bart B.A., Teerlink J.R., Jaski B.E., Fang J.C., Feller E.D., Haas G.J., Anderson A.S., Schollmeyer M.P., Sobotka PA, and UNLOAD Trial Investigators. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49 (2007) 675-683
10. Basile C., Chimienti D., Bruno A., Cocola S., Libutti P., Teutonico A., and Cazzato F. Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure. Perit Dial Int 29 (2009) 116-118
11. Kagan A., and Rapoport J. The role of peritoneal dialysis in the treatment of refractory heart failure. Nephrol Dial Transplant 20 (2005) 28-31
12. Kazory A., and Ross E.A. Contemporary trends in the pharmacological and extracorporeal management of heart failure: a nephrologic perspective. Circulation 117 (2008) 975-983
13. Mehrotra R., Nolph K.D., and Gotch F. Early initiation of chronic dialysis: role of incremental dialysis. Perit Dial Int 17 (1997) 426-430
14. Viglino G., Neri L., and Barbieri S. Incremental peritoneal dialysis: effects on the choice of dialysis modality, residual renal function and adequacy. Kidney Int Suppl 108 (2008) S52-S55
15. Nakayama M. Studies on the sodium concentration of dialysate solution for continuous ambulatory peritoneal dialysis. Nippon Jinzo Gakkai Shi 34 (1992) 913-920 (in Japanese)
16. Agostoni P.G., and Marenzi G.C. Sustained benefit from ultrafiltration in moderate congestive heart failure. Cardiology 96 (2001) 183-189
17. Kazory A., and Ejaz A.A. Removal of BNP and inflammatory cytokines by haemodiafiltration in refractory heart failure. Nephrol Dial Transplant 22 (2007) 2093-2094
18. Hörl W.H., and Riegel W. Cardiac depressant factors in renal disease. Circulation 87 (1993) 77-82
19. Zemel D., Imholz A.L., de Waart D.R., Dinkla C., Struijk D.G., and Krediet R.T. Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Kidney Int 46 (1994) 1422-1430
20. Fincher M.E., Campbell H.T., Sklar A.H., Caruana R.J., Lightfoot B.O., Cheek P.L., Smith K.L., and Hess C.P. Atrial natriuretic peptide (ANP) is removed by peritoneal dialysis in humans. Adv Perit Dial 5 (1989) 16-19
21. Silverberg D.S., Wexler D., and Iaina A. The role of anemia in congestive heart failure and chronic kidney insufficiency: the cardio renal anemia syndrome. Perspect Biol Med 47 (2004) 575-589
22. Silverberg D.S., Wexler D., Blum M., Iaina A., Sheps D., Keren G., Scherhag A., and Schwartz D. Effects of treatment with epoetin beta on outcomes in patients with anaemia and chronic heart failure. Kidney Blood Press Res 28 (2005) 41-47
23. Palazzuoli A., Silverberg D.S., Iovine F., Calabrò A., Campagna M.S., Gallotta M., and Nuti R. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome. Am Heart J 154 (2007) e9-e15
24. Akdag I., Yilmaz Y., Kahvecioglu S., Bolca N., Ercan I., Ersoy A., and Gullulu M. Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study. Nephron Clin Pract 108 (2008) c99-105
25. Nakamoto H., Kawaguchi Y., and Suzuki H. Is technique survival on peritoneal dialysis better in Japan?. Perit Dial Int 26 (2006) 136-143